Vir Biotechnology Scientists Named Winners of the BARDA and HHS-Sponsored Pediatric COVID-19 Data ChallengeGlobeNewsWire • 04/06/22
Vir Biotechnology to Participate in the 21st Annual Needham Healthcare ConferenceGlobeNewsWire • 04/04/22
Vir Biotechnology, Inc. (VIR) Moves 14.8% Higher: Will This Strength Last?Zacks Investment Research • 03/31/22
Camden Property Trust Set to Join S&P 500; Matador Resources to Join S&P MidCap 400; Vir Biotechnology to Join S&P SmallCap 600PRNewsWire • 03/29/22
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron SubvariantBenzinga • 03/28/22
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 SubvariantGlobeNewsWire • 03/25/22
These 3 Stocks Aren't Large Caps Yet, but They Each Could Make $1 Billion in Sales in 2022The Motley Fool • 03/25/22
Vir Biotechnology to Participate in the 42nd Annual Cowen Healthcare ConferenceGlobeNewsWire • 03/02/22
After Plunging 26.6% in 4 Weeks, Here's Why the Trend Might Reverse for Vir Biotechnology, Inc. (VIR)Zacks Investment Research • 03/01/22
Vir Biotechnology, Inc. (VIR) Q4 Earnings and Revenues Beat EstimatesZacks Investment Research • 02/25/22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 02/24/22
Vir Biotechnology, Inc. (VIR) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 02/17/22